Recently,Johnson & Johnson (NYSE: JNJ) Global Vice President of Medical Technology and Group Chief Information Officer Larry Jones will leave the world's second-largest medical device manufacturer.He will retire from Johnson & Johnson's medical device business. Details such as his current status, when he will officially leave, or who will replace him are still unknown.

Recently, Larry Jones announced that he will retire from Johnson & Johnson's medical device business.When asked about when he would officially leave or whether there would be someone to replace him, he said that he would share more details when the information could be made public. Johnson & Johnson Medical Technologies did not respond to requests for further information.

Jones is a goal-oriented leader who drives transformative change through key principles such as business process integration, agile methodologies, and next-generation technology solutions. He focuses on advancing Johnson & Johnson's oncology, orthopedics, cardiovascular, and general surgery robotics and machine learning platforms to promote digital surgical connectivity solutions.He served as the cross-regional Global Chief Information Officer at Janssen Pharmaceuticals for over 6 years.He is an executive member of the Johnson & Johnson African American Leadership Council and the Johnson & Johnson Regional Diversity and Inclusion Leadership Council, and also a member of the Healthcare Industry Advisory Boards of Microsoft and Verizon. In 2019, Jones was honored by ITSMF and the Harlem Fine Arts Festival for his lifetime achievements as an African American in the technology field. He was also nominated as the 2019 New York/New Jersey CIO of the Year by InspireCIO.

Jones holds a Master’s degree in Computer Engineering/MBA from the University of Pennsylvania and Wharton School. He also earned a Bachelor’s degree in Computer Science from Saint Peter’s University.

Jones wrote on LinkedIn: "After an incredible 35 years at Johnson & Johnson, I am beginning to reflect on the extraordinary journey we have shared."

"For friends and partners along the way, this is not a farewell — just 'see you later,'" he later added, expressing that he is about to embark on "an exciting new chapter in life and career."

"Our dedication to patients, communities, customers, and employees has always inspired me, and I am incredibly proud of what we have achieved," Jones wrote in the LinkedIn post. "Our success is a testament to the exceptional global team and leaders I have had the privilege to work with, who have fostered a family-like atmosphere that has made every challenge worthwhile. … I leave with countless precious memories, stories, and experiences. Thank you all."

"I would like to sincerely thank my family for their unwavering support, especially my wife—my coach, whose love and encouragement are invaluable to me," he continued. "I also want to thank my father, who is a great and humble role model. He instilled in me a strong and resilient work ethic."

"As I embark on this exciting new chapter in my life and career, I remain committed to harnessing technology for the benefit of humanity, advancing global health equity, and combating chronic diseases," Jones concluded.

On his LinkedIn page, Jones stated that his recent accomplishments include "completing a three-year, $200 million global digital transformation initiative to drive lean business processes, cloud-based solutions, and integrated insights."

Johnson & Johnson Medical Technology has experienced frequent personnel changes in the past year.

Just this month a year ago, Ashley McEvoy announced her surprising decision to step down as the Global Chair of Johnson & Johnson’s Medical Technology division. She continued to serve in an advisory role until February 2024, after which Tim Schmid took over as the head of the medical device business.

This Year8Month, having worked at Johnson & Johnson for nearly20Executive Vice President and Chief Human Resources OfficerPeter Fasolo Plans to retire at the end of this year. Has worked at Johnson & Johnson for nearly20Year,Peter Fasolo Plan to retire at the end of this year. Company selectionKristen MulhollandReplace him, from10Month1Effective from the date. Fasolo and Muholland will collaborate during a transition period until Fasolo's official retirement.

In addition, there are several personnel changes in Johnson & Johnson's China region:

In August this year,Kevin Chen (Chu-Hui Chen), General Manager of Johnson & Johnson Medical Technology China’s Cardiovascular and Professional Solutions Division, and Head of External Affairs and Market Access, has submitted his resignation to the company and is seeking opportunities for external development.. He worked at Johnson & Johnson until September 16, 2024. During the transition period, Edward Zhou will temporarily take over the management of the Cardiovascular and Specialty Solutions division as well as the External Affairs and Market Access departments. Chen Chuhui joined Johnson & Johnson in 2009, holding managerial positions in the Ethicon ASP division, Endo division's Harmonic scalpel business, Gynecare division, and Mentor division. After returning to Johnson & Johnson in 2015, he also took on important leadership roles such as Head of Channel Management, Strategic Customers, Operations, and Professional Education.

July,Johnson & Johnson announced that Edward Zhou (Zhou Mintao) will assume the position of President of Johnson & Johnson Medical Technologies China on July 25, 2024, while also becoming a member of the Johnson & Johnson Medical Technologies Asia-Pacific leadership team.Zhou Mintao had nearly three decades of work experience at Johnson & Johnson. He joined the company's consumer products business as a sales representative in 1992 and later became the General Manager of Johnson & Johnson's consumer products business in Singapore. After returning to China, he served as the General Manager of Johnson & Johnson's consumer products business in China. In 2015, he was appointed Vice President of the Ethicon division’s surgical business and became the General Manager of the Ethicon division in China in 2016.

4Month,Johnson & Johnson Announces Departure of Song Weiqun, Chairman of China Region and President of Johnson & Johnson Medical Technology China.2003In that year, Song Weiqun joined Johnson & Johnson at the U.S. headquarters as the only global management trainee of that year.Will SongOnly one company on the resume so far: Johnson & Johnson. The first China-born Chairman of Johnson & Johnson's China branch.

April,Johnson & Johnson announces Ronnie Chen as the Human Resources Leader for Johnson & Johnson Medical Technology China & OneHR China.Chen Yanli is the former Vice President of Talent and Organizational Culture at Roche Pharmaceuticals China and the head of the Hospital Key Account Management Department for Market Access in China.

Late March,Johnson & Johnson Medical Technologies announced Tulio Oliveira as the new General Manager of its Surgical Division in China.Before joining the China team, Tulio served as the Global Head of Johnson & Johnson Medical Technologies' Advanced Stapling business. Tulio joined Johnson & Johnson in 2003 as an Ethicon sales representative for the Brazilian market. He subsequently worked in Brazil, the United States, Chile, and Argentina, with responsibilities spanning sales, marketing, new business development, global strategic marketing, strategic planning, and general management.

---

How will Johnson & Johnson's recent personnel changes drive its further development? Will they better help Johnson & Johnson meet market changes and demands? Medical Device News will continue to follow.

END

 

More exciting content

Welcome to follow WeChat Video Channel

Instrument Family

Related Reading

Tap for more!

 

Midea Invests, Chinese-Made Surgical Robot Company Dissolved

Top 100 Medical Device Companies Build New Headquarters

650,000 Products Recalled, Orthopedic Leader Declares Bankruptcy

Philips: Layoffs, This Business Transfer

Medtronic Announces Chief Medical Officer from Cleveland Clinic

United Imaging First, Top Rankings of County DR Market in Recent Three Years

GE Healthcare, this product was manufactured in the U.S. for the first time

1.45 Billion, "The Layout of China's Leading Domestic Imaging Core Component Manufacturer"

How to Develop During the "Reverse Globalization" Period? Responses from Medtronic, GE Healthcare, and Philips

Mayo Clinic: Layoffs, Restructuring

BusinessBusiness cooperation email: qxzj@landianyiliao.com